Precigen PGEN
NASDAQ PGEN
$7.11 -0.03 (-0.49%)
As of: Sep 4, 2026 · 3:59 PM EDT

Precigen (PGEN) Other Operating Expenses (2013 - 2026)

Precigen (PGEN) posted quarterly Other Operating Expenses of $2.6 million for Q1 2026, up 132.64% year-over-year from $1.1 million in Q1 2025, and up 60.34% quarter-over-quarter from $1.6 million in Q4 2025.

Analysis

Precigen (PGEN) Other Operating Expenses (2013 - 2026) Analysis & Trends

Precigen (PGEN) has reported Other Operating Expenses for 15 consecutive years, with $2.6 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Other Operating Expenses rose 132.64% year-over-year to $2.6 million; the TTM figure through Mar 2026 stood at $10.2 million (down 77.16% YoY), while the FY2025 annual figure was $8.7 million, down 80.42% from the prior year.
  • Other Operating Expenses advanced to $2.6 million in Q1 2026 per PGEN's latest filing, from $1.6 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $35.6 million in Q2 2024 and bottomed at $1.0 million in Q3 2024.
  • Historically, Other Operating Expenses has averaged $4.7 million across 5 years, with a median of $1.6 million in 2025.
  • Annual changes were most pronounced in 2024 — Other Operating Expenses soared 1995.4% — and 2025, when it tumbled 85.94%.
  • Precigen's Other Operating Expenses stood at $1.3 million in 2022, then jumped by 870.01% to $12.2 million in 2023, then tumbled by 43.02% to $6.9 million in 2024, then tumbled by 77.03% to $1.6 million in 2025, then soared by 60.34% to $2.6 million in 2026.
  • Business Quant data shows PGEN's Other Operating Expenses at $2.6 million in Q1 2026, $1.6 million in Q4 2025, and $1.0 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Precigen 2.53 Bn 2.53 Bn 52.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.81 Mn
Mar 31, 2026 2.56 Mn
Dec 31, 2025 1.60 Mn
Sep 30, 2025 1.04 Mn
Jun 30, 2025 5.00 Mn
Mar 31, 2025 1.10 Mn
Dec 31, 2024 6.95 Mn
Sep 30, 2024 1.01 Mn
Jun 30, 2024 35.56 Mn
Mar 31, 2024 1.08 Mn
Dec 31, 2023 12.19 Mn
Sep 30, 2023 1.54 Mn
Jun 30, 2023 1.70 Mn
Mar 31, 2023 1.53 Mn
Dec 31, 2022 1.26 Mn
Sep 30, 2022 1.58 Mn
Jun 30, 2022 2.45 Mn
Mar 31, 2022 2.18 Mn
Dec 31, 2021 1.58 Mn
Sep 30, 2021 1.45 Mn